Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
|Slideshows|November 14, 2018
Dermatoses of Childhood: 7 Photoclinic Cases
Author(s)Robert B. Blereau, MD
Can you diagnose these 7 cases of dermatoses? Scroll through our Photoclinic to find out.
Advertisement
These seven Photoclinic cases offer a good look at and a brief overview of common dermatologic conditions of childhood. (This presentation updates the original, posted in 2016.)
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Patient Care Online
1
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
2
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
3
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
4
Unmet Needs and Mechanisms Behind Newer Agitation Therapies
5